PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$864M
This Quarter Return
-0.86%
1 Year Return
+33.7%
3 Year Return
+258.24%
5 Year Return
+878.92%
10 Year Return
–
AUM
$272M
AUM Growth
+$272M
(-21%)
Cap. Flow
-$18.7M
Cap. Flow
% of AUM
-6.88%
Top 10 Holdings %
Top 10 Hldgs %
40.84%
Holding
92
New
12
Increased
38
Reduced
26
Closed
16
Top Buys
| 1 |
Waters Corp
WAT
|
$8.69M |
| 2 |
Elevance Health
ELV
|
$8.57M |
| 3 |
Ionis Pharmaceuticals
IONS
|
$6.45M |
| 4 |
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
|
$4.93M |
| 5 |
United Therapeutics
UTHR
|
$4.17M |
Top Sells
| 1 |
BioCryst Pharmaceuticals
BCRX
|
$7.76M |
| 2 |
AbbVie
ABBV
|
$7.41M |
| 3 |
Idexx Laboratories
IDXX
|
$5.14M |
| 4 |
Aclaris Therapeutics
ACRS
|
$5.07M |
| 5 |
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
|
$4.87M |
Sector Composition
| 1 | Healthcare | 96.48% |
| 2 | Industrials | 1.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Schrodinger
SDGR
$1.42B
| $3.23M | 1.19% |
122,225
+6,334
| +5% | +$167K |
|
27
ANI Pharmaceuticals
ANIP
$2.06B
| $3.22M | 1.19% |
108,559
+648
| +0.6% | +$19.2K |
|
28
Arcellx
ACLX
$3.95B
| $3.22M | 1.19% |
+178,000
| New | +$3.22M |
|
29
Procept Biorobotics
PRCT
$2.11B
| $3.09M | 1.14% |
+94,500
| New | +$3.09M |
|
30
908 Devices
MASS
$214M
| $3.07M | 1.13% |
149,315
-25,685
| -15% | -$529K |
|
31
Insulet
PODD
$24.2B
| $3.03M | 1.11% |
13,889
+1,218
| +10% | +$265K |
|
32
Alnylam Pharmaceuticals
ALNY
$58.6B
| $3.02M | 1.11% |
20,734
-33,274
| -62% | -$4.85M |
|
33
MannKind Corp
MNKD
$1.69B
| $2.91M | 1.07% |
764,814
+89,411
| +13% | +$341K |
|
|
PHLT
34
Performant Healthcare, Inc. Common Stock
PHLT
$602M
| $2.66M | 0.98% |
1,011,324
+54,241
| +6% | +$143K |
|
35
Natera
NTRA
$23B
| $2.62M | 0.97% |
74,047
-55,897
| -43% | -$1.98M |
|
36
Cogent Biosciences
COGT
$1.83B
| $2.61M | 0.96% |
+288,750
| New | +$2.61M |
|
37
DexCom
DXCM
$30.9B
| $2.6M | 0.96% |
34,834
-16,114
| -32% | -$1.2M |
|
38
Supernus Pharmaceuticals
SUPN
$2.52B
| $2.56M | 0.94% |
88,658
-20,296
| -19% | -$587K |
|
|
AKYA
39
DELISTED
Akoya BioSciences
AKYA
| $2.37M | 0.87% |
184,785
+34,464
| +23% | +$443K |
|
|
APEN
40
DELISTED
Apollo Endosurgery, Inc.
APEN
| $2.37M | 0.87% |
650,000
-160,411
| -20% | -$586K |
|
41
Immunic
IMUX
$79.4M
| $2.26M | 0.83% |
650,028
-439,223
| -40% | -$1.52M |
|
42
Codexis
CDXS
$218M
| $2.13M | 0.79% |
204,049
-64,095
| -24% | -$670K |
|
43
Day One Biopharmaceuticals
DAWN
$766M
| $2.05M | 0.76% |
+114,750
| New | +$2.05M |
|
|
IMGO
44
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
| $1.97M | 0.73% |
147,387
+7,636
| +5% | +$102K |
|
45
KORU Medical Systems
KRMD
$187M
| $1.71M | 0.63% |
675,434
+2,977
| +0.4% | +$7.53K |
|
46
Haemonetics
HAE
$2.57B
| $1.63M | 0.6% |
+25,000
| New | +$1.63M |
|
47
RxSight
RXST
$364M
| $1.62M | 0.6% |
+115,000
| New | +$1.62M |
|
48
Axogen
AXGN
$723M
| $1.54M | 0.57% |
188,494
+59,547
| +46% | +$488K |
|
49
Madrigal Pharmaceuticals
MDGL
$9.7B
| $1.53M | 0.56% |
21,336
+1,106
| +5% | +$79.2K |
|
50
Veracyte
VCYT
$2.41B
| $1.47M | 0.54% |
73,966
+13,315
| +22% | +$265K |
|